Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$6.01 - $8.35 $118,192 - $164,211
19,666 Added 31.41%
82,280 $687,000
Q3 2022

Nov 09, 2022

BUY
$5.57 - $7.46 $348,759 - $467,100
62,614 New
62,614 $356,000
Q2 2020

Aug 12, 2020

SELL
$7.16 - $12.33 $369,434 - $636,191
-51,597 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$6.08 - $16.42 $384,681 - $1.04 Million
-63,270 Reduced 55.08%
51,597 $422,000
Q4 2019

Feb 05, 2020

SELL
$10.57 - $13.84 $122,823 - $160,820
-11,620 Reduced 9.19%
114,867 $1.38 Million
Q3 2019

Nov 20, 2019

BUY
$10.51 - $13.32 $28,986 - $36,736
2,758 Added 2.23%
126,487 $1.54 Million
Q2 2019

Aug 09, 2019

BUY
$12.7 - $15.49 $397,014 - $484,232
31,261 Added 33.81%
123,729 $1.64 Million
Q1 2019

May 03, 2019

SELL
$13.93 - $17.91 $12,982 - $16,692
-932 Reduced 1.0%
92,468 $1.39 Million
Q4 2018

Feb 07, 2019

SELL
$14.25 - $19.66 $488,775 - $674,338
-34,300 Reduced 26.86%
93,400 $1.7 Million
Q3 2018

Nov 14, 2018

BUY
$12.25 - $16.29 $700,700 - $931,788
57,200 Added 81.13%
127,700 $1.99 Million
Q2 2018

Aug 03, 2018

BUY
$9.99 - $14.05 $704,295 - $990,525
70,500 New
70,500 $890,000

Others Institutions Holding SPNE

About SeaSpine Holdings Corp


  • Ticker SPNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,202,800
  • Description
  • SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion pr...
More about SPNE
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.